Skip to main content
. 2022 Oct 3;13:1018748. doi: 10.3389/fmicb.2022.1018748

Figure 5.

Figure 5

Evaluation of the therapeutic effect of chimeric IgG/IgA produced by CHO cell line. Piglets feces (A) and intestinal tract (B) in group 2 (one day after IgG/IgA treatment) and 3 (no antibody treatment). (C) The PEDV RNA copies in the feces of piglets, the error bars indicated standard deviation. Data were analyzed using two-way ANOVA by time. (D) IHC and HE assay of the piglets in group 1 (unchallenged), 2 (IgG/IgA treatment) and 3 (no antibody treatment). dpi, day-post-infection.